Literature DB >> 32895514

Gelling hypotonic polymer solution for extended topical drug delivery to the eye.

Yoo Chun Kim1,2, Matthew D Shin1,2, Sean F Hackett2, Henry T Hsueh1,3, Raquel Lima E Silva2, Abhijit Date1,2,4, Hyounkoo Han1,2, Byung-Jin Kim2, Amy Xiao1,5, Youngwook Kim1,6, Laolu Ogunnaike1,3, Nicole M Anders7, Avelina Hemingway7, Ping He7, Albert S Jun2, Peter J McDonnell2, Charles Eberhart2, Ian Pitha2, Donald J Zack1,2, Peter A Campochiaro2, Justin Hanes8,9,10,11,12,13,14, Laura M Ensign15,16,17,18,19,20,21,22.   

Abstract

Eye-drop formulations should hold as high a concentration of soluble drug in contact with ocular epithelium for as long as possible. However, eye tears and frequent blinking limit drug retention on the ocular surface, and gelling drops typically form clumps that blur vision. Here, we describe a gelling hypotonic solution containing a low concentration of a thermosensitive triblock copolymer for extended ocular drug delivery. On topical application, the hypotonic formulation forms a highly uniform and clear thin layer that conforms to the ocular surface and resists clearance from blinking, increasing the intraocular absorption of hydrophilic and hydrophobic drugs and extending the drug-ocular-epithelium contact time with respect to conventional thermosensitive gelling formulations and commercial eye drops. We also show that the conformal gel layer allows for therapeutically relevant drug delivery to the posterior segment of the eyeball in pigs. Our findings highlight the importance of formulations that conform to the ocular surface before viscosity enhancement for increased and prolonged ocular surface contact and drug absorption.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32895514      PMCID: PMC7655548          DOI: 10.1038/s41551-020-00606-8

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  49 in total

Review 1.  Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.

Authors:  J J Escobar-Chávez; M López-Cervantes; A Naïk; Y N Kalia; D Quintanar-Guerrero; A Ganem-Quintanar
Journal:  J Pharm Pharm Sci       Date:  2006       Impact factor: 2.327

2.  A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue.

Authors:  Elizabeth A Nance; Graeme F Woodworth; Kurt A Sailor; Ting-Yu Shih; Qingguo Xu; Ganesh Swaminathan; Dennis Xiang; Charles Eberhart; Justin Hanes
Journal:  Sci Transl Med       Date:  2012-08-29       Impact factor: 17.956

Review 3.  Particle tracking in drug and gene delivery research: State-of-the-art applications and methods.

Authors:  Benjamin S Schuster; Laura M Ensign; Daniel B Allan; Jung Soo Suk; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2015-04-07       Impact factor: 15.470

4.  Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.

Authors:  Manuel Marcel Hermann; Dimitris Papaconstantinou; Philipp Sebastian Muether; Gerasimos Georgopoulos; Michael Diestelhorst
Journal:  Acta Ophthalmol       Date:  2010-11-25       Impact factor: 3.761

5.  Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.

Authors:  Zeinab M A Fathalla; Anil Vangala; Michael Longman; Khaled A Khaled; Amal K Hussein; Omar H El-Garhy; Raid G Alany
Journal:  Eur J Pharm Biopharm       Date:  2017-01-24       Impact factor: 5.571

6.  Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms.

Authors:  Sunil Deokule; Saghir Sadiq; Sunil Shah
Journal:  Ophthalmic Physiol Opt       Date:  2004-01       Impact factor: 3.117

7.  Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2007-03-07       Impact factor: 3.575

8.  The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.

Authors:  Antonia M Joussen; Sebastian Wolf; Peter K Kaiser; David Boyer; Thomas Schmelter; Rupert Sandbrink; Oliver Zeitz; Gesa Deeg; Annett Richter; Torsten Zimmermann; Joachim Hoechel; Ulf Buetehorn; Walter Schmitt; Brigitte Stemper; Michael K Boettger
Journal:  Br J Clin Pharmacol       Date:  2018-11-25       Impact factor: 4.335

9.  Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.

Authors:  Shinya Horita; Miwa Watanabe; Mai Katagiri; Hiroaki Nakamura; Hiroki Haniuda; Tomoyuki Nakazato; Yoshiyuki Kagawa
Journal:  Pharmacol Res Perspect       Date:  2019-11-20

Review 10.  Managing adverse effects of glaucoma medications.

Authors:  Kenji Inoue
Journal:  Clin Ophthalmol       Date:  2014-05-12
View more
  14 in total

Review 1.  Lab-on-a-Contact Lens: Recent Advances and Future Opportunities in Diagnostics and Therapeutics.

Authors:  Yangzhi Zhu; Shaopei Li; Jinghang Li; Natashya Falcone; Qingyu Cui; Shilp Shah; Martin C Hartel; Ning Yu; Patric Young; Natan Roberto de Barros; Zhuohong Wu; Reihaneh Haghniaz; Menekse Ermis; Canran Wang; Heemin Kang; Junmin Lee; Solmaz Karamikamkar; Samad Ahadian; Vadim Jucaud; Mehmet R Dokmeci; Han-Jun Kim; Ali Khademhosseini
Journal:  Adv Mater       Date:  2022-04-11       Impact factor: 32.086

Review 2.  Translational Applications of Hydrogels.

Authors:  Santiago Correa; Abigail K Grosskopf; Hector Lopez Hernandez; Doreen Chan; Anthony C Yu; Lyndsay M Stapleton; Eric A Appel
Journal:  Chem Rev       Date:  2021-05-03       Impact factor: 60.622

3.  A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.

Authors:  Yoo Chun Kim; Henry T Hsueh; Matthew D Shin; Cynthia A Berlinicke; Hyounkoo Han; Nicole M Anders; Avelina Hemingway; Kirby T Leo; Renee Ti Chou; HyeYoung Kwon; Matthew B Appell; Usha Rai; Patricia Kolodziejski; Charles Eberhart; Ian Pitha; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Drug Deliv Transl Res       Date:  2021-04-26       Impact factor: 4.617

Review 4.  The Role of Eph Receptors and Ephrins in Corneal Physiology and Diseases.

Authors:  Radoslaw Kaczmarek; Katarzyna Zimmer; Pawel Gajdzis; Malgorzata Gajdzis
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  A long-term retaining molecular coating for corneal regeneration.

Authors:  Yi Zhang; Chenglin Li; Qiuwen Zhu; Renjie Liang; Chang Xie; Shufang Zhang; Yi Hong; Hongwei Ouyang
Journal:  Bioact Mater       Date:  2021-05-05

Review 6.  Hydrogels in Burn Wound Management-A Review.

Authors:  Agnieszka Surowiecka; Jerzy Strużyna; Aleksandra Winiarska; Tomasz Korzeniowski
Journal:  Gels       Date:  2022-02-15

7.  Celastrol-based nanomedicine promotes corneal allograft survival.

Authors:  Zhanrong Li; Ruixing Liu; Zhihua Guo; Dandan Chu; Lei Zhu; Junjie Zhang; Xintao Shuai; Jingguo Li
Journal:  J Nanobiotechnology       Date:  2021-10-26       Impact factor: 10.435

8.  Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells.

Authors:  Henry T Hsueh; Yoo-Chun Kim; Ian Pitha; Matthew D Shin; Cynthia A Berlinicke; Renee Ti Chou; Elizabeth Kimball; Julie Schaub; Sarah Quillen; Kirby T Leo; Hyounkoo Han; Amy Xiao; Youngwook Kim; Matthew Appell; Usha Rai; HyeYoung Kwon; Patricia Kolodziejski; Laolu Ogunnaike; Nicole M Anders; Avelina Hemingway; Joan L Jefferys; Abhijit A Date; Charles Eberhart; Thomas V Johnson; Harry A Quigley; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Pharmaceutics       Date:  2021-05-01       Impact factor: 6.321

9.  Induction of the integrated stress response in the rat cornea.

Authors:  C Peterson; Y C Kim; L M Ensign; A S Jun; J Foster
Journal:  Exp Eye Res       Date:  2021-08-08       Impact factor: 3.770

10.  In Situ Gelling Systems Using Pluronic F127 Enhance Corneal Permeability of Indomethacin Nanocrystals.

Authors:  Noriaki Nagai; Takumi Isaka; Saori Deguchi; Misa Minami; Mizuki Yamaguchi; Hiroko Otake; Norio Okamoto; Yosuke Nakazawa
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.